Lobbying Governance
| Overall Assessment | Analysis | Score |
|---|---|---|
| Limited |
Cardinal Health makes a high-level statement that it will “conduct [its] engagement activities in line with the goals of the Paris Agreement,” signalling an intention to align external advocacy with climate objectives, yet the company’s detailed disclosures focus almost entirely on general ESG oversight. The Board’s Governance and Sustainability Committee is said to provide “formal oversight of enterprise ESG activities, policies, strategies, and reporting,” and an internal ESG Governance Committee of senior leaders “is responsible for approving and tracking progress against enterprise-wide ESG strategies.” While these structures demonstrate broad sustainability governance, the evidence does not describe any specific mechanisms for monitoring or managing lobbying activities, no mention of reviewing trade-association positions, and no procedures for correcting or exiting misaligned advocacy. We found no disclosure of a lobbying-alignment audit, no description of how direct or indirect lobbying is tracked against climate goals, and no individual or committee explicitly identified as responsible for lobbying governance. Consequently, the company’s lobbying governance is limited to the overarching Paris-agreement commitment without an accompanying process to ensure that lobbying actually aligns with it.
View Sources
|
D |